antifibrotic therapy

Advertisement

cGxPJobs Banner

Vanda Gains EMA Orphan Status for Imsidolimab in GPP

WASHINGTON, July 16, 2026 Vanda Pharmaceuticals has announced that the Committee for Orphan Medicinal Products (COMP) at the European...

By cGxPwire Editor
July 18, 2026

Read More

Boehringer Ingelheim Wins EU Approval for JASCAYD

INGELHEIM, Germany, July 17, 2026 Boehringer Ingelheim has announced that the European Commission (EC) has granted marketing authorization for...

By cGxPwire Editor
July 18, 2026

Read More

Celea Doses First Patient in Phase 3 SURPASS-IPF Trial

BOSTON, July 13, 2026 Celea Therapeutics announced that the first patient has been dosed in the global Phase 3...

By cGxPwire Editor
July 14, 2026

Read More

Deupirfenidone Shows Strong IPF Results in Phase 2b Study

NEW YORK, April 2, 2026 PureTech Health plc has announced the publication of its Phase 2b ELEVATE IPF trial...

By cGxPwire Editor
April 3, 2026

Read More

Advertisement

cGxPJobs

Directory